Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Space | 3 | 2010 | 87 | 0.690 |
Why?
|
| Cell Physiological Phenomena | 2 | 2010 | 25 | 0.550 |
Why?
|
| Mitochondria | 5 | 2025 | 612 | 0.540 |
Why?
|
| Insulin-Secreting Cells | 4 | 2011 | 441 | 0.530 |
Why?
|
| Calcium | 4 | 2010 | 1175 | 0.500 |
Why?
|
| Insulin | 3 | 2011 | 1185 | 0.440 |
Why?
|
| Microelectrodes | 3 | 2010 | 87 | 0.430 |
Why?
|
| Biofouling | 1 | 2014 | 2 | 0.410 |
Why?
|
| Biofilms | 1 | 2014 | 50 | 0.400 |
Why?
|
| Seawater | 1 | 2014 | 51 | 0.400 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2025 | 7 | 0.380 |
Why?
|
| Protein Deglycase DJ-1 | 2 | 2025 | 6 | 0.380 |
Why?
|
| Dopaminergic Neurons | 2 | 2025 | 30 | 0.370 |
Why?
|
| Glycosyltransferases | 2 | 2020 | 20 | 0.320 |
Why?
|
| Potassium | 2 | 2009 | 232 | 0.310 |
Why?
|
| Chlorides | 2 | 2008 | 100 | 0.310 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 6 | 0.310 |
Why?
|
| Ion-Selective Electrodes | 1 | 2010 | 5 | 0.310 |
Why?
|
| Malates | 1 | 2009 | 6 | 0.300 |
Why?
|
| Malate Dehydrogenase | 1 | 2009 | 9 | 0.300 |
Why?
|
| Pyruvate Carboxylase | 1 | 2009 | 6 | 0.300 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2009 | 20 | 0.290 |
Why?
|
| Ion Channel Gating | 1 | 2009 | 302 | 0.250 |
Why?
|
| Sodium | 1 | 2008 | 329 | 0.250 |
Why?
|
| Biological Clocks | 1 | 2007 | 76 | 0.240 |
Why?
|
| Database Management Systems | 1 | 2006 | 44 | 0.230 |
Why?
|
| Glucose | 4 | 2011 | 692 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 126 | 0.230 |
Why?
|
| Mesencephalon | 1 | 2025 | 67 | 0.220 |
Why?
|
| User-Computer Interface | 1 | 2006 | 189 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 98 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 193 | 0.210 |
Why?
|
| Organizers, Embryonic | 1 | 2023 | 6 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2025 | 175 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 170 | 0.180 |
Why?
|
| Sports for Persons with Disabilities | 1 | 2021 | 1 | 0.180 |
Why?
|
| Youth Sports | 1 | 2021 | 8 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2006 | 1006 | 0.170 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 453 | 0.170 |
Why?
|
| Biochemistry | 1 | 2020 | 28 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2020 | 94 | 0.150 |
Why?
|
| Adenosine Triphosphate | 4 | 2023 | 315 | 0.150 |
Why?
|
| Plants | 1 | 2020 | 118 | 0.150 |
Why?
|
| Exercise | 1 | 2021 | 353 | 0.140 |
Why?
|
| Succinates | 2 | 2009 | 25 | 0.140 |
Why?
|
| Antitrichomonal Agents | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ferrous Compounds | 1 | 2016 | 18 | 0.130 |
Why?
|
| Arabidopsis | 1 | 2020 | 326 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 77 | 0.130 |
Why?
|
| Antimalarials | 1 | 2016 | 21 | 0.120 |
Why?
|
| Animals | 12 | 2023 | 28041 | 0.120 |
Why?
|
| Quinolines | 1 | 2016 | 85 | 0.120 |
Why?
|
| Mice | 7 | 2019 | 12233 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2007 | 405 | 0.110 |
Why?
|
| Proton-Translocating ATPases | 1 | 2014 | 24 | 0.110 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 11 | 0.110 |
Why?
|
| Benzothiazoles | 1 | 2014 | 17 | 0.110 |
Why?
|
| Cricetulus | 2 | 2016 | 122 | 0.100 |
Why?
|
| CHO Cells | 2 | 2016 | 187 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2017 | 962 | 0.100 |
Why?
|
| Biomass | 1 | 2014 | 43 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2014 | 241 | 0.100 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2014 | 42 | 0.100 |
Why?
|
| Home Care Services | 1 | 2015 | 77 | 0.100 |
Why?
|
| Phospholipids | 1 | 2014 | 107 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 237 | 0.100 |
Why?
|
| Phosphates | 1 | 2014 | 163 | 0.100 |
Why?
|
| Hydrogen Peroxide | 2 | 2011 | 164 | 0.090 |
Why?
|
| Meningococcal Infections | 1 | 2012 | 1 | 0.090 |
Why?
|
| Purpura Fulminans | 1 | 2012 | 2 | 0.090 |
Why?
|
| Vitamin K 3 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2015 | 376 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 279 | 0.090 |
Why?
|
| Bacteremia | 1 | 2012 | 108 | 0.090 |
Why?
|
| Cytosol | 2 | 2009 | 192 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2012 | 124 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 238 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 24 | 0.080 |
Why?
|
| Cell Wall | 2 | 2020 | 71 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 58 | 0.070 |
Why?
|
| Diffusion | 1 | 2009 | 90 | 0.070 |
Why?
|
| Citric Acid | 1 | 2009 | 47 | 0.070 |
Why?
|
| Rats | 3 | 2011 | 4042 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1339 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 192 | 0.070 |
Why?
|
| Cricetinae | 1 | 2009 | 532 | 0.070 |
Why?
|
| Artifacts | 1 | 2010 | 243 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1516 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 378 | 0.070 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2008 | 38 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 215 | 0.070 |
Why?
|
| Ions | 1 | 2008 | 78 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 797 | 0.070 |
Why?
|
| Mitochondrial Membranes | 2 | 2019 | 20 | 0.060 |
Why?
|
| NADP | 1 | 2007 | 48 | 0.060 |
Why?
|
| Glucose-6-Phosphate | 1 | 2007 | 3 | 0.060 |
Why?
|
| Keto Acids | 1 | 2007 | 5 | 0.060 |
Why?
|
| Pyruvates | 1 | 2007 | 12 | 0.060 |
Why?
|
| Palmitates | 1 | 2007 | 17 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2010 | 2828 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2756 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 282 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2009 | 661 | 0.060 |
Why?
|
| Chlamydomonas | 1 | 2005 | 20 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2025 | 27 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 34 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 947 | 0.060 |
Why?
|
| Lilium | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2025 | 46 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 1119 | 0.050 |
Why?
|
| Pollen | 1 | 2004 | 84 | 0.050 |
Why?
|
| Male | 6 | 2025 | 44578 | 0.050 |
Why?
|
| Humans | 10 | 2025 | 93615 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2023 | 138 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 1768 | 0.050 |
Why?
|
| Time Factors | 2 | 2010 | 5406 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2005 | 299 | 0.050 |
Why?
|
| Apoptosis | 2 | 2014 | 1719 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 150 | 0.040 |
Why?
|
| Recreation | 1 | 2021 | 9 | 0.040 |
Why?
|
| Cell Size | 1 | 2002 | 71 | 0.040 |
Why?
|
| Perciformes | 1 | 2002 | 41 | 0.040 |
Why?
|
| Zygote | 1 | 2002 | 44 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1243 | 0.040 |
Why?
|
| Pediatricians | 1 | 2021 | 24 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2021 | 52 | 0.040 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 32 | 0.040 |
Why?
|
| Xylans | 1 | 2020 | 1 | 0.040 |
Why?
|
| Glucans | 1 | 2020 | 10 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 134 | 0.040 |
Why?
|
| Physician's Role | 1 | 2021 | 176 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2020 | 114 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2002 | 346 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 230 | 0.040 |
Why?
|
| Homeostasis | 1 | 2002 | 460 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 32 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2021 | 298 | 0.040 |
Why?
|
| Hypoxia | 1 | 2023 | 675 | 0.030 |
Why?
|
| Child | 2 | 2021 | 7359 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 696 | 0.030 |
Why?
|
| United States | 3 | 2017 | 7645 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2017 | 40 | 0.030 |
Why?
|
| Trichomonas vaginalis | 1 | 2016 | 3 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2016 | 55 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 133 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 176 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1528 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1302 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2002 | 1019 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 1003 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2121 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 39 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 490 | 0.030 |
Why?
|
| Telemedicine | 1 | 2017 | 225 | 0.030 |
Why?
|
| Omentum | 1 | 2014 | 68 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 392 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 192 | 0.020 |
Why?
|
| Netherlands | 1 | 2012 | 25 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3430 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 10 | 0.020 |
Why?
|
| Female | 4 | 2025 | 48779 | 0.020 |
Why?
|
| Insulinoma | 1 | 2011 | 38 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 295 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 938 | 0.020 |
Why?
|
| NAD | 1 | 2011 | 96 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 410 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 1061 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 502 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9610 | 0.020 |
Why?
|
| Quality of Life | 1 | 2017 | 1783 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2011 | 557 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2020 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1735 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1913 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 3832 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20469 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2543 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 196 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 715 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 27621 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 3222 | 0.010 |
Why?
|
| Fresh Water | 1 | 2005 | 22 | 0.010 |
Why?
|
| Spain | 1 | 2005 | 33 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 99 | 0.010 |
Why?
|
| Fluorescence | 1 | 2005 | 100 | 0.010 |
Why?
|
| Anion Exchange Resins | 1 | 2004 | 2 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 138 | 0.010 |
Why?
|
| Chloride Channels | 1 | 2004 | 43 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 2375 | 0.010 |
Why?
|
| Quinine | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2002 | 15 | 0.010 |
Why?
|
| Mercuric Chloride | 1 | 2002 | 11 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 17 | 0.010 |
Why?
|
| Population Density | 1 | 2002 | 70 | 0.010 |
Why?
|
| Muscle Relaxants, Central | 1 | 2002 | 11 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 59 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 121 | 0.010 |
Why?
|
| Oxidants | 1 | 2002 | 86 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 390 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 683 | 0.010 |
Why?
|